| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |